CGRRF1 and breast carcinoma: By analyzing the methylation status of the CGRRF1 promoter, we show that the CGRRF1 promoter region is hypermethylated in breast cancer tissues and demonstrate that the expression of CGRRF1 can be restored by 5-azacitidine and panobinostat, which might be considered as part of the therapy for these patients.